nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—Pleural disorder—Riluzole—amyotrophic lateral sclerosis	0.0495	0.0654	CcSEcCtD
Bexarotene—Tamibarotene—RARA—amyotrophic lateral sclerosis	0.0357	1	CrCbGaD
Bexarotene—Subdural haematoma—Riluzole—amyotrophic lateral sclerosis	0.0223	0.0294	CcSEcCtD
Bexarotene—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0222	CcSEcCtD
Bexarotene—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0199	CcSEcCtD
Bexarotene—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.0143	0.0189	CcSEcCtD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.0126	0.0635	CbGpPWpGaD
Bexarotene—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0166	CcSEcCtD
Bexarotene—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.012	0.0159	CcSEcCtD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.0119	0.0597	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—RARA—amyotrophic lateral sclerosis	0.0113	0.0566	CbGpPWpGaD
Bexarotene—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.011	0.0145	CcSEcCtD
Bexarotene—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.011	0.0145	CcSEcCtD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—RARA—amyotrophic lateral sclerosis	0.0106	0.0532	CbGpPWpGaD
Bexarotene—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00996	0.0131	CcSEcCtD
Bexarotene—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00996	0.0131	CcSEcCtD
Bexarotene—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.00952	0.0126	CcSEcCtD
Bexarotene—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00952	0.0126	CcSEcCtD
Bexarotene—RXRG—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00932	0.0468	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00876	0.044	CbGpPWpGaD
Bexarotene—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00854	0.0113	CcSEcCtD
Bexarotene—RXRG—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00844	0.0424	CbGpPWpGaD
Bexarotene—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00844	0.0111	CcSEcCtD
Bexarotene—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00823	0.0109	CcSEcCtD
Bexarotene—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00813	0.0107	CcSEcCtD
Bexarotene—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00794	0.0105	CcSEcCtD
Bexarotene—RXRB—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00794	0.0399	CbGpPWpGaD
Bexarotene—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00785	0.0104	CcSEcCtD
Bexarotene—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00776	0.0102	CcSEcCtD
Bexarotene—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00759	0.01	CcSEcCtD
Bexarotene—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00743	0.00981	CcSEcCtD
Bexarotene—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00743	0.00981	CcSEcCtD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00736	0.037	CbGpPWpGaD
Bexarotene—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00735	0.00971	CcSEcCtD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00692	0.0348	CbGpPWpGaD
Bexarotene—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00685	0.00905	CcSEcCtD
Bexarotene—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.00672	0.00887	CcSEcCtD
Bexarotene—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.0066	0.00871	CcSEcCtD
Bexarotene—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00631	0.00833	CcSEcCtD
Bexarotene—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00626	0.00826	CcSEcCtD
Bexarotene—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00626	0.00826	CcSEcCtD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.00619	0.0311	CbGpPWpGaD
Bexarotene—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0061	0.00805	CcSEcCtD
Bexarotene—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.006	0.00792	CcSEcCtD
Bexarotene—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00568	0.00749	CcSEcCtD
Bexarotene—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00563	0.00744	CcSEcCtD
Bexarotene—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00555	0.00733	CcSEcCtD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—RARA—amyotrophic lateral sclerosis	0.00552	0.0277	CbGpPWpGaD
Bexarotene—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00535	0.00707	CcSEcCtD
Bexarotene—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00514	0.00678	CcSEcCtD
Bexarotene—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00514	0.00678	CcSEcCtD
Bexarotene—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00674	CcSEcCtD
Bexarotene—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00674	CcSEcCtD
Bexarotene—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00665	CcSEcCtD
Bexarotene—Gout—Riluzole—amyotrophic lateral sclerosis	0.005	0.0066	CcSEcCtD
Bexarotene—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00652	CcSEcCtD
Bexarotene—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00648	CcSEcCtD
Bexarotene—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00632	CcSEcCtD
Bexarotene—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00617	CcSEcCtD
Bexarotene—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00617	CcSEcCtD
Bexarotene—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00609	CcSEcCtD
Bexarotene—RXRA—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00457	0.023	CbGpPWpGaD
Bexarotene—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00602	CcSEcCtD
Bexarotene—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00451	0.00595	CcSEcCtD
Bexarotene—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00451	0.00595	CcSEcCtD
Bexarotene—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00589	CcSEcCtD
Bexarotene—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00585	CcSEcCtD
Bexarotene—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00566	CcSEcCtD
Bexarotene—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00557	CcSEcCtD
Bexarotene—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00557	CcSEcCtD
Bexarotene—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00549	CcSEcCtD
Bexarotene—RXRA—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00414	0.0208	CbGpPWpGaD
Bexarotene—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00409	0.0054	CcSEcCtD
Bexarotene—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00405	0.00535	CcSEcCtD
Bexarotene—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00405	0.00535	CcSEcCtD
Bexarotene—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00525	CcSEcCtD
Bexarotene—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00525	CcSEcCtD
Bexarotene—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00515	CcSEcCtD
Bexarotene—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00379	0.005	CcSEcCtD
Bexarotene—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00379	0.005	CcSEcCtD
Bexarotene—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00494	CcSEcCtD
Bexarotene—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00483	CcSEcCtD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00361	0.0181	CbGpPWpGaD
Bexarotene—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00476	CcSEcCtD
Bexarotene—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00474	CcSEcCtD
Bexarotene—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00356	0.0047	CcSEcCtD
Bexarotene—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00464	CcSEcCtD
Bexarotene—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00461	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00348	0.0175	CbGpPWpGaD
Bexarotene—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0034	0.00449	CcSEcCtD
Bexarotene—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00448	CcSEcCtD
Bexarotene—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00444	CcSEcCtD
Bexarotene—RXRA—Organelle biogenesis and maintenance—GFM1—amyotrophic lateral sclerosis	0.00334	0.0168	CbGpPWpGaD
Bexarotene—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00441	CcSEcCtD
Bexarotene—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00441	CcSEcCtD
Bexarotene—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00432	CcSEcCtD
Bexarotene—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00426	CcSEcCtD
Bexarotene—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00424	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.0032	0.0161	CbGpPWpGaD
Bexarotene—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00421	CcSEcCtD
Bexarotene—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00416	CcSEcCtD
Bexarotene—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00413	CcSEcCtD
Bexarotene—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00407	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00305	0.00403	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.003	0.0151	CbGpPWpGaD
Bexarotene—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00395	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00395	CcSEcCtD
Bexarotene—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00389	CcSEcCtD
Bexarotene—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00387	CcSEcCtD
Bexarotene—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00387	CcSEcCtD
Bexarotene—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00379	CcSEcCtD
Bexarotene—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00285	0.00377	CcSEcCtD
Bexarotene—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00372	CcSEcCtD
Bexarotene—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.0028	0.0141	CbGpPWpGaD
Bexarotene—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00367	CcSEcCtD
Bexarotene—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00362	CcSEcCtD
Bexarotene—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00362	CcSEcCtD
Bexarotene—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00357	CcSEcCtD
Bexarotene—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00356	CcSEcCtD
Bexarotene—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00353	CcSEcCtD
Bexarotene—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00352	CcSEcCtD
Bexarotene—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00265	0.0035	CcSEcCtD
Bexarotene—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00347	CcSEcCtD
Bexarotene—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00338	CcSEcCtD
Bexarotene—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00336	CcSEcCtD
Bexarotene—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00336	CcSEcCtD
Bexarotene—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00335	CcSEcCtD
Bexarotene—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00331	CcSEcCtD
Bexarotene—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00329	CcSEcCtD
Bexarotene—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00325	CcSEcCtD
Bexarotene—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00324	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00242	0.0122	CbGpPWpGaD
Bexarotene—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00311	CcSEcCtD
Bexarotene—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0031	CcSEcCtD
Bexarotene—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0031	CcSEcCtD
Bexarotene—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00308	CcSEcCtD
Bexarotene—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00307	CcSEcCtD
Bexarotene—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00306	CcSEcCtD
Bexarotene—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00305	CcSEcCtD
Bexarotene—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00304	CcSEcCtD
Bexarotene—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00304	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00228	0.0114	CbGpPWpGaD
Bexarotene—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00289	CcSEcCtD
Bexarotene—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00287	CcSEcCtD
Bexarotene—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00281	CcSEcCtD
Bexarotene—Chills—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00278	CcSEcCtD
Bexarotene—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00277	CcSEcCtD
Bexarotene—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00274	CcSEcCtD
Bexarotene—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0027	CcSEcCtD
Bexarotene—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00266	CcSEcCtD
Bexarotene—Tension—Riluzole—amyotrophic lateral sclerosis	0.002	0.00264	CcSEcCtD
Bexarotene—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.002	0.00264	CcSEcCtD
Bexarotene—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00262	CcSEcCtD
Bexarotene—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00261	CcSEcCtD
Bexarotene—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00259	CcSEcCtD
Bexarotene—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0025	CcSEcCtD
Bexarotene—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00249	CcSEcCtD
Bexarotene—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00248	CcSEcCtD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00186	0.00937	CbGpPWpGaD
Bexarotene—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00243	CcSEcCtD
Bexarotene—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00242	CcSEcCtD
Bexarotene—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00242	CcSEcCtD
Bexarotene—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00241	CcSEcCtD
Bexarotene—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00238	CcSEcCtD
Bexarotene—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00237	CcSEcCtD
Bexarotene—Cough—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00235	CcSEcCtD
Bexarotene—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00233	CcSEcCtD
Bexarotene—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00229	CcSEcCtD
Bexarotene—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00229	CcSEcCtD
Bexarotene—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00229	CcSEcCtD
Bexarotene—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00229	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00228	CcSEcCtD
Bexarotene—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00227	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00171	0.00858	CbGpPWpGaD
Bexarotene—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00224	CcSEcCtD
Bexarotene—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00222	CcSEcCtD
Bexarotene—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0022	CcSEcCtD
Bexarotene—Infection—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00219	CcSEcCtD
Bexarotene—Shock—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00216	CcSEcCtD
Bexarotene—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00216	CcSEcCtD
Bexarotene—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00215	CcSEcCtD
Bexarotene—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00215	CcSEcCtD
Bexarotene—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00214	CcSEcCtD
Bexarotene—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00213	CcSEcCtD
Bexarotene—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0021	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00157	0.00787	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00154	0.00774	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00154	0.00773	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00152	0.002	CcSEcCtD
Bexarotene—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00199	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.0015	0.00753	CbGpPWpGaD
Bexarotene—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00198	CcSEcCtD
Bexarotene—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00196	CcSEcCtD
Bexarotene—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00196	CcSEcCtD
Bexarotene—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00194	CcSEcCtD
Bexarotene—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00191	CcSEcCtD
Bexarotene—RXRB—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00145	0.00727	CbGpPWpGaD
Bexarotene—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0019	CcSEcCtD
Bexarotene—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0019	CcSEcCtD
Bexarotene—Pain—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00188	CcSEcCtD
Bexarotene—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00188	CcSEcCtD
Bexarotene—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00181	CcSEcCtD
Bexarotene—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0018	CcSEcCtD
Bexarotene—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00174	CcSEcCtD
Bexarotene—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00174	CcSEcCtD
Bexarotene—RXRG—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00131	0.00658	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00127	0.00639	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00125	0.00631	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00123	0.00618	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00123	0.00618	CbGpPWpGaD
Bexarotene—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00162	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.0012	0.00601	CbGpPWpGaD
Bexarotene—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00158	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00119	0.00596	CbGpPWpGaD
Bexarotene—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00156	CcSEcCtD
Bexarotene—RXRG—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00117	0.00586	CbGpPWpGaD
Bexarotene—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00151	CcSEcCtD
Bexarotene—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00145	CcSEcCtD
Bexarotene—RXRB—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.0011	0.00551	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.0011	0.00551	CbGpPWpGaD
Bexarotene—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0014	CcSEcCtD
Bexarotene—Rash—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00139	CcSEcCtD
Bexarotene—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00139	CcSEcCtD
Bexarotene—Headache—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00138	CcSEcCtD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000997	0.00501	CbGpPWpGaD
Bexarotene—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00099	0.00131	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000925	0.00465	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000912	0.00459	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000863	0.00434	CbGpPWpGaD
Bexarotene—RXRG—medulla oblongata—amyotrophic lateral sclerosis	0.000855	0.109	CbGeAlD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000848	0.00426	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000845	0.00425	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000837	0.00421	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000808	0.00406	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000797	0.00401	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000788	0.00396	CbGpPWpGaD
Bexarotene—RXRG—spinal cord—amyotrophic lateral sclerosis	0.000762	0.0972	CbGeAlD
Bexarotene—RXRB—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00076	0.00382	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000754	0.00379	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000751	0.00378	CbGpPWpGaD
Bexarotene—RXRA—nervous system—amyotrophic lateral sclerosis	0.000732	0.0933	CbGeAlD
Bexarotene—RXRG—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000728	0.00366	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000719	0.00361	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000706	0.00355	CbGpPWpGaD
Bexarotene—RXRA—central nervous system—amyotrophic lateral sclerosis	0.000705	0.0898	CbGeAlD
Bexarotene—RXRB—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000684	0.00344	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000661	0.00332	CbGpPWpGaD
Bexarotene—RXRG—nervous system—amyotrophic lateral sclerosis	0.000642	0.0819	CbGeAlD
Bexarotene—RXRA—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000641	0.00322	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000623	0.00313	CbGpPWpGaD
Bexarotene—RXRG—central nervous system—amyotrophic lateral sclerosis	0.000619	0.0788	CbGeAlD
Bexarotene—RXRG—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000612	0.00308	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000609	0.00306	CbGpPWpGaD
Bexarotene—RXRB—nervous system—amyotrophic lateral sclerosis	0.000604	0.077	CbGeAlD
Bexarotene—RXRB—central nervous system—amyotrophic lateral sclerosis	0.000582	0.0741	CbGeAlD
Bexarotene—RXRA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00058	0.00291	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000576	0.00289	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.000571	0.00287	CbGpPWpGaD
Bexarotene—RXRB—cerebellum—amyotrophic lateral sclerosis	0.000568	0.0725	CbGeAlD
Bexarotene—RXRA—brain—amyotrophic lateral sclerosis	0.000559	0.0713	CbGeAlD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000547	0.00275	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000534	0.00269	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000528	0.00266	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000513	0.00258	CbGpPWpGaD
Bexarotene—RXRG—brain—amyotrophic lateral sclerosis	0.000491	0.0626	CbGeAlD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00049	0.00246	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000484	0.00243	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000463	0.00233	CbGpPWpGaD
Bexarotene—RXRB—brain—amyotrophic lateral sclerosis	0.000462	0.0589	CbGeAlD
Bexarotene—RXRA—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000453	0.00228	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000444	0.00223	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000444	0.00223	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000414	0.00208	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000406	0.00204	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000396	0.00199	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000394	0.00198	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000394	0.00198	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000378	0.0019	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000372	0.00187	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—FUS—amyotrophic lateral sclerosis	0.000368	0.00185	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000357	0.00179	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000355	0.00179	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000351	0.00176	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000341	0.00171	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000333	0.00167	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000321	0.00161	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000319	0.0016	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000317	0.00159	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000301	0.00151	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RARA—amyotrophic lateral sclerosis	0.0003	0.00151	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000298	0.0015	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000276	0.00139	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000256	0.00129	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000243	0.00122	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000225	0.00113	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000218	0.00109	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000216	0.00109	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000213	0.00107	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000205	0.00103	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000204	0.00103	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000184	0.000927	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000168	0.000846	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000166	0.000834	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000166	0.000834	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000164	0.000826	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000155	0.000777	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000152	0.000762	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000143	0.000717	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000141	0.000709	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000141	0.000708	CbGpPWpGaD
Bexarotene—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000135	0.0172	CbGeAlD
Bexarotene—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000133	0.000666	CbGpPWpGaD
Bexarotene—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00013	0.0166	CbGeAlD
Bexarotene—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	0.00012	0.000603	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000115	0.00058	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000113	0.000569	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000109	0.00055	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000109	0.00055	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000102	0.000511	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.0001	0.000503	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.91e-05	0.000498	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.3e-05	0.000467	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.11e-05	0.000458	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	9.09e-05	0.000457	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	8.74e-05	0.00044	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	8.39e-05	0.000422	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.91e-05	0.000397	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.64e-05	0.000384	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—APOE—amyotrophic lateral sclerosis	7.5e-05	0.000377	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	6.89e-05	0.000346	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.28e-05	0.000316	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.99e-05	0.000301	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.53e-05	0.000278	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.14e-05	0.000258	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.54e-05	0.000228	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.31e-05	0.000216	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.7e-05	0.000186	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.4e-05	0.000171	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.8e-05	0.000141	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.44e-05	0.000123	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.24e-05	0.000113	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.92e-05	9.64e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.85e-05	9.28e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.26e-05	6.36e-05	CbGpPWpGaD
